nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—ABCG2—Sulfasalazine—Crohn's disease	0.212	0.55	CbGbCtD
Venlafaxine—CYP2C19—Prednisone—Crohn's disease	0.0757	0.196	CbGbCtD
Venlafaxine—ABCB1—Prednisone—Crohn's disease	0.0611	0.159	CbGbCtD
Venlafaxine—CYP3A4—Prednisone—Crohn's disease	0.0366	0.095	CbGbCtD
Venlafaxine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CPEB4—Crohn's disease	0.00406	0.0552	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide GPCRs—CCR9—Crohn's disease	0.00321	0.0436	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.00229	0.0312	CbGpPWpGaD
Venlafaxine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CPEB4—Crohn's disease	0.00219	0.0298	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—MLN—Crohn's disease	0.00217	0.0296	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide GPCRs—CCR6—Crohn's disease	0.00212	0.0289	CbGpPWpGaD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.0018	0.0245	CbGpPWpGaD
Venlafaxine—SLC6A3—Parkinsons Disease Pathway—LRRK2—Crohn's disease	0.00178	0.0243	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00154	0.0209	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.00151	0.0205	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00146	0.0199	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—CCR9—Crohn's disease	0.00127	0.0173	CbGpPWpGaD
Venlafaxine—Necrosis—Prednisone—Crohn's disease	0.00119	0.0022	CcSEcCtD
Venlafaxine—Liver function test abnormal—Mesalazine—Crohn's disease	0.00118	0.00218	CcSEcCtD
Venlafaxine—SLC6A4—Serotonin Transporter Activity—IL1B—Crohn's disease	0.00118	0.0161	CbGpPWpGaD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00118	0.0161	CbGpPWpGaD
Venlafaxine—Dry skin—Mesalazine—Crohn's disease	0.00117	0.00217	CcSEcCtD
Venlafaxine—NPY1R—GPCR ligand binding—ACKR2—Crohn's disease	0.00117	0.016	CbGpPWpGaD
Venlafaxine—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00117	0.00216	CcSEcCtD
Venlafaxine—Oedema—Mercaptopurine—Crohn's disease	0.00116	0.00214	CcSEcCtD
Venlafaxine—Pancytopenia—Azathioprine—Crohn's disease	0.00115	0.00213	CcSEcCtD
Venlafaxine—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00115	0.00213	CcSEcCtD
Venlafaxine—Cramp muscle—Mesalazine—Crohn's disease	0.00115	0.00213	CcSEcCtD
Venlafaxine—Glycosuria—Prednisone—Crohn's disease	0.00115	0.00213	CcSEcCtD
Venlafaxine—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00114	0.0021	CcSEcCtD
Venlafaxine—Petechiae—Prednisone—Crohn's disease	0.00113	0.0021	CcSEcCtD
Venlafaxine—Gastritis—Mesalazine—Crohn's disease	0.00113	0.00209	CcSEcCtD
Venlafaxine—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00113	0.00209	CcSEcCtD
Venlafaxine—Abdominal distension—Mesalazine—Crohn's disease	0.00111	0.00206	CcSEcCtD
Venlafaxine—NPY1R—GPCR ligand binding—MLN—Crohn's disease	0.00111	0.0151	CbGpPWpGaD
Venlafaxine—Asthma—Mesalazine—Crohn's disease	0.00111	0.00204	CcSEcCtD
Venlafaxine—Influenza—Mesalazine—Crohn's disease	0.00111	0.00204	CcSEcCtD
Venlafaxine—Dysphagia—Mesalazine—Crohn's disease	0.00111	0.00204	CcSEcCtD
Venlafaxine—Anorexia—Mercaptopurine—Crohn's disease	0.00111	0.00204	CcSEcCtD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.0011	0.0149	CbGpPWpGaD
Venlafaxine—Eosinophilia—Mesalazine—Crohn's disease	0.0011	0.00202	CcSEcCtD
Venlafaxine—Pneumonia—Azathioprine—Crohn's disease	0.00109	0.00201	CcSEcCtD
Venlafaxine—Delirium—Prednisone—Crohn's disease	0.00109	0.00201	CcSEcCtD
Venlafaxine—Pancreatitis—Mesalazine—Crohn's disease	0.00109	0.002	CcSEcCtD
Venlafaxine—Angina pectoris—Mesalazine—Crohn's disease	0.00108	0.00199	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00107	0.00198	CcSEcCtD
Venlafaxine—Bronchitis—Mesalazine—Crohn's disease	0.00106	0.00197	CcSEcCtD
Venlafaxine—Amenorrhoea—Prednisone—Crohn's disease	0.00106	0.00196	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00106	0.00195	CcSEcCtD
Venlafaxine—Pancytopenia—Mesalazine—Crohn's disease	0.00105	0.00194	CcSEcCtD
Venlafaxine—Neutropenia—Mesalazine—Crohn's disease	0.00104	0.00191	CcSEcCtD
Venlafaxine—Dysuria—Mesalazine—Crohn's disease	0.00104	0.00191	CcSEcCtD
Venlafaxine—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00103	0.0019	CcSEcCtD
Venlafaxine—Arthropathy—Prednisone—Crohn's disease	0.00103	0.0019	CcSEcCtD
Venlafaxine—Pollakiuria—Mesalazine—Crohn's disease	0.00102	0.00189	CcSEcCtD
Venlafaxine—Agranulocytosis—Azathioprine—Crohn's disease	0.00101	0.00187	CcSEcCtD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00101	0.0138	CbGpPWpGaD
Venlafaxine—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00101	0.00187	CcSEcCtD
Venlafaxine—Decreased appetite—Mercaptopurine—Crohn's disease	0.00101	0.00186	CcSEcCtD
Venlafaxine—Weight increased—Mesalazine—Crohn's disease	0.00101	0.00186	CcSEcCtD
Venlafaxine—Weight decreased—Mesalazine—Crohn's disease	0.001	0.00185	CcSEcCtD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.000999	0.0136	CbGpPWpGaD
Venlafaxine—Leukocytosis—Prednisone—Crohn's disease	0.000993	0.00184	CcSEcCtD
Venlafaxine—Pneumonia—Mesalazine—Crohn's disease	0.000993	0.00183	CcSEcCtD
Venlafaxine—Hypercholesterolaemia—Prednisone—Crohn's disease	0.000987	0.00182	CcSEcCtD
Venlafaxine—Depression—Mesalazine—Crohn's disease	0.000984	0.00182	CcSEcCtD
Venlafaxine—Cataract—Prednisone—Crohn's disease	0.000981	0.00181	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000978	0.00181	CcSEcCtD
Venlafaxine—Haemoglobin—Azathioprine—Crohn's disease	0.000978	0.00181	CcSEcCtD
Venlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000976	0.0133	CbGpPWpGaD
Venlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000976	0.0133	CbGpPWpGaD
Venlafaxine—Haemorrhage—Azathioprine—Crohn's disease	0.000973	0.0018	CcSEcCtD
Venlafaxine—Renal failure—Mesalazine—Crohn's disease	0.00097	0.00179	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000967	0.00179	CcSEcCtD
Venlafaxine—Stomatitis—Mesalazine—Crohn's disease	0.000962	0.00178	CcSEcCtD
Venlafaxine—Jaundice—Mesalazine—Crohn's disease	0.000962	0.00178	CcSEcCtD
Venlafaxine—Conjunctivitis—Mesalazine—Crohn's disease	0.000959	0.00177	CcSEcCtD
Venlafaxine—Sweating—Mesalazine—Crohn's disease	0.000946	0.00175	CcSEcCtD
Venlafaxine—Haematuria—Mesalazine—Crohn's disease	0.000941	0.00174	CcSEcCtD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00094	0.0128	CbGpPWpGaD
Venlafaxine—Hiccups—Prednisone—Crohn's disease	0.000934	0.00172	CcSEcCtD
Venlafaxine—Epistaxis—Mesalazine—Crohn's disease	0.000931	0.00172	CcSEcCtD
Venlafaxine—Sinusitis—Mesalazine—Crohn's disease	0.000926	0.00171	CcSEcCtD
Venlafaxine—Agranulocytosis—Mesalazine—Crohn's disease	0.000921	0.0017	CcSEcCtD
Venlafaxine—Erythema multiforme—Azathioprine—Crohn's disease	0.00092	0.0017	CcSEcCtD
Venlafaxine—Body temperature increased—Mercaptopurine—Crohn's disease	0.000917	0.00169	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—CREM—Crohn's disease	0.000913	0.0124	CbGpPWpGaD
Venlafaxine—Haemoglobin—Mesalazine—Crohn's disease	0.00089	0.00165	CcSEcCtD
Venlafaxine—Rhinitis—Mesalazine—Crohn's disease	0.000888	0.00164	CcSEcCtD
Venlafaxine—Haemorrhage—Mesalazine—Crohn's disease	0.000886	0.00164	CcSEcCtD
Venlafaxine—Hepatitis—Mesalazine—Crohn's disease	0.000886	0.00164	CcSEcCtD
Venlafaxine—Pharyngitis—Mesalazine—Crohn's disease	0.000879	0.00162	CcSEcCtD
Venlafaxine—Neuropathy—Prednisone—Crohn's disease	0.000876	0.00162	CcSEcCtD
Venlafaxine—Chills—Azathioprine—Crohn's disease	0.000873	0.00161	CcSEcCtD
Venlafaxine—Arrhythmia—Azathioprine—Crohn's disease	0.000869	0.00161	CcSEcCtD
Venlafaxine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000865	0.0118	CbGpPWpGaD
Venlafaxine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000865	0.0118	CbGpPWpGaD
Venlafaxine—Alopecia—Azathioprine—Crohn's disease	0.00086	0.00159	CcSEcCtD
Venlafaxine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000854	0.00158	CcSEcCtD
Venlafaxine—Oesophagitis—Prednisone—Crohn's disease	0.000853	0.00158	CcSEcCtD
Venlafaxine—Ecchymosis—Prednisone—Crohn's disease	0.000844	0.00156	CcSEcCtD
Venlafaxine—NPY1R—G alpha (i) signalling events—CCR6—Crohn's disease	0.000842	0.0115	CbGpPWpGaD
Venlafaxine—Erythema multiforme—Mesalazine—Crohn's disease	0.000838	0.00155	CcSEcCtD
Venlafaxine—Tinnitus—Mesalazine—Crohn's disease	0.000826	0.00153	CcSEcCtD
Venlafaxine—Cardiac disorder—Mesalazine—Crohn's disease	0.000822	0.00152	CcSEcCtD
Venlafaxine—Hyperkinesia—Prednisone—Crohn's disease	0.000814	0.0015	CcSEcCtD
Venlafaxine—Euphoric mood—Prednisone—Crohn's disease	0.000802	0.00148	CcSEcCtD
Venlafaxine—Chills—Mesalazine—Crohn's disease	0.000795	0.00147	CcSEcCtD
Venlafaxine—Diarrhoea—Mercaptopurine—Crohn's disease	0.000794	0.00147	CcSEcCtD
Venlafaxine—Ill-defined disorder—Azathioprine—Crohn's disease	0.000786	0.00145	CcSEcCtD
Venlafaxine—Alopecia—Mesalazine—Crohn's disease	0.000783	0.00145	CcSEcCtD
Venlafaxine—Thrombophlebitis—Prednisone—Crohn's disease	0.000783	0.00145	CcSEcCtD
Venlafaxine—Anaemia—Azathioprine—Crohn's disease	0.000783	0.00145	CcSEcCtD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000782	0.0106	CbGpPWpGaD
Venlafaxine—Diabetes mellitus—Prednisone—Crohn's disease	0.000779	0.00144	CcSEcCtD
Venlafaxine—Erythema—Mesalazine—Crohn's disease	0.000771	0.00142	CcSEcCtD
Venlafaxine—NPY1R—GPCR ligand binding—CCR9—Crohn's disease	0.00077	0.0105	CbGpPWpGaD
Venlafaxine—Malaise—Azathioprine—Crohn's disease	0.000764	0.00141	CcSEcCtD
Venlafaxine—Flatulence—Mesalazine—Crohn's disease	0.00076	0.0014	CcSEcCtD
Venlafaxine—Leukopenia—Azathioprine—Crohn's disease	0.000758	0.0014	CcSEcCtD
Venlafaxine—Vascular purpura—Prednisone—Crohn's disease	0.000757	0.0014	CcSEcCtD
Venlafaxine—Tension—Mesalazine—Crohn's disease	0.000757	0.0014	CcSEcCtD
Venlafaxine—Dysgeusia—Mesalazine—Crohn's disease	0.000755	0.0014	CcSEcCtD
Venlafaxine—Nervousness—Mesalazine—Crohn's disease	0.000749	0.00138	CcSEcCtD
Venlafaxine—Cardiac failure congestive—Prednisone—Crohn's disease	0.000747	0.00138	CcSEcCtD
Venlafaxine—Back pain—Mesalazine—Crohn's disease	0.000746	0.00138	CcSEcCtD
Venlafaxine—SLC6A4—Circadian rythm related genes—CREM—Crohn's disease	0.000745	0.0101	CbGpPWpGaD
Venlafaxine—Muscle spasms—Mesalazine—Crohn's disease	0.000742	0.00137	CcSEcCtD
Venlafaxine—Vomiting—Mercaptopurine—Crohn's disease	0.000737	0.00136	CcSEcCtD
Venlafaxine—Injury—Prednisone—Crohn's disease	0.000737	0.00136	CcSEcCtD
Venlafaxine—Rash—Mercaptopurine—Crohn's disease	0.000731	0.00135	CcSEcCtD
Venlafaxine—Dermatitis—Mercaptopurine—Crohn's disease	0.000731	0.00135	CcSEcCtD
Venlafaxine—Vision blurred—Mesalazine—Crohn's disease	0.000727	0.00134	CcSEcCtD
Venlafaxine—Tremor—Mesalazine—Crohn's disease	0.000723	0.00133	CcSEcCtD
Venlafaxine—Amnesia—Prednisone—Crohn's disease	0.000721	0.00133	CcSEcCtD
Venlafaxine—Increased appetite—Prednisone—Crohn's disease	0.000721	0.00133	CcSEcCtD
Venlafaxine—Arthralgia—Azathioprine—Crohn's disease	0.000721	0.00133	CcSEcCtD
Venlafaxine—Myalgia—Azathioprine—Crohn's disease	0.000721	0.00133	CcSEcCtD
Venlafaxine—NPY1R—GPCR ligand binding—GPR65—Crohn's disease	0.000716	0.00975	CbGpPWpGaD
Venlafaxine—Ill-defined disorder—Mesalazine—Crohn's disease	0.000716	0.00132	CcSEcCtD
Venlafaxine—Anaemia—Mesalazine—Crohn's disease	0.000713	0.00132	CcSEcCtD
Venlafaxine—Discomfort—Azathioprine—Crohn's disease	0.000712	0.00132	CcSEcCtD
Venlafaxine—Angioedema—Mesalazine—Crohn's disease	0.000705	0.0013	CcSEcCtD
Venlafaxine—Purpura—Prednisone—Crohn's disease	0.000703	0.0013	CcSEcCtD
Venlafaxine—Malaise—Mesalazine—Crohn's disease	0.000696	0.00128	CcSEcCtD
Venlafaxine—Vertigo—Mesalazine—Crohn's disease	0.000693	0.00128	CcSEcCtD
Venlafaxine—Syncope—Mesalazine—Crohn's disease	0.000692	0.00128	CcSEcCtD
Venlafaxine—Leukopenia—Mesalazine—Crohn's disease	0.00069	0.00128	CcSEcCtD
Venlafaxine—Nausea—Mercaptopurine—Crohn's disease	0.000689	0.00127	CcSEcCtD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000688	0.00937	CbGpPWpGaD
Venlafaxine—Infection—Azathioprine—Crohn's disease	0.000687	0.00127	CcSEcCtD
Venlafaxine—Palpitations—Mesalazine—Crohn's disease	0.000682	0.00126	CcSEcCtD
Venlafaxine—Loss of consciousness—Mesalazine—Crohn's disease	0.000678	0.00125	CcSEcCtD
Venlafaxine—Osteoarthritis—Prednisone—Crohn's disease	0.000678	0.00125	CcSEcCtD
Venlafaxine—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000678	0.00125	CcSEcCtD
Venlafaxine—Thrombocytopenia—Azathioprine—Crohn's disease	0.000677	0.00125	CcSEcCtD
Venlafaxine—Cough—Mesalazine—Crohn's disease	0.000673	0.00124	CcSEcCtD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00067	0.00912	CbGpPWpGaD
Venlafaxine—Affect lability—Prednisone—Crohn's disease	0.000667	0.00123	CcSEcCtD
Venlafaxine—Hypertension—Mesalazine—Crohn's disease	0.000666	0.00123	CcSEcCtD
Venlafaxine—Psychotic disorder—Prednisone—Crohn's disease	0.000662	0.00122	CcSEcCtD
Venlafaxine—Myalgia—Mesalazine—Crohn's disease	0.000657	0.00121	CcSEcCtD
Venlafaxine—Chest pain—Mesalazine—Crohn's disease	0.000657	0.00121	CcSEcCtD
Venlafaxine—Arthralgia—Mesalazine—Crohn's disease	0.000657	0.00121	CcSEcCtD
Venlafaxine—Anxiety—Mesalazine—Crohn's disease	0.000654	0.00121	CcSEcCtD
Venlafaxine—Face oedema—Prednisone—Crohn's disease	0.000654	0.00121	CcSEcCtD
Venlafaxine—Discomfort—Mesalazine—Crohn's disease	0.000649	0.0012	CcSEcCtD
Venlafaxine—Irritability—Prednisone—Crohn's disease	0.000647	0.00119	CcSEcCtD
Venlafaxine—Hypotension—Azathioprine—Crohn's disease	0.000646	0.00119	CcSEcCtD
Venlafaxine—Cardiac arrest—Prednisone—Crohn's disease	0.000644	0.00119	CcSEcCtD
Venlafaxine—Dry mouth—Mesalazine—Crohn's disease	0.000642	0.00119	CcSEcCtD
Venlafaxine—Mood swings—Prednisone—Crohn's disease	0.000642	0.00119	CcSEcCtD
Venlafaxine—Confusional state—Mesalazine—Crohn's disease	0.000635	0.00117	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00063	0.00116	CcSEcCtD
Venlafaxine—Oedema—Mesalazine—Crohn's disease	0.000629	0.00116	CcSEcCtD
Venlafaxine—Anaphylactic shock—Mesalazine—Crohn's disease	0.000629	0.00116	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—MLN—Crohn's disease	0.000628	0.00855	CbGpPWpGaD
Venlafaxine—Infection—Mesalazine—Crohn's disease	0.000625	0.00116	CcSEcCtD
Venlafaxine—Dry skin—Prednisone—Crohn's disease	0.000621	0.00115	CcSEcCtD
Venlafaxine—Shock—Mesalazine—Crohn's disease	0.000619	0.00114	CcSEcCtD
Venlafaxine—Hypokalaemia—Prednisone—Crohn's disease	0.000617	0.00114	CcSEcCtD
Venlafaxine—Thrombocytopenia—Mesalazine—Crohn's disease	0.000616	0.00114	CcSEcCtD
Venlafaxine—Tachycardia—Mesalazine—Crohn's disease	0.000614	0.00113	CcSEcCtD
Venlafaxine—Hyperhidrosis—Mesalazine—Crohn's disease	0.000609	0.00112	CcSEcCtD
Venlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000608	0.00828	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—ACKR2—Crohn's disease	0.000601	0.00819	CbGpPWpGaD
Venlafaxine—Anorexia—Mesalazine—Crohn's disease	0.0006	0.00111	CcSEcCtD
Venlafaxine—Muscular weakness—Prednisone—Crohn's disease	0.000598	0.0011	CcSEcCtD
Venlafaxine—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000598	0.0011	CcSEcCtD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00059	0.00803	CbGpPWpGaD
Venlafaxine—Abdominal distension—Prednisone—Crohn's disease	0.00059	0.00109	CcSEcCtD
Venlafaxine—Hypotension—Mesalazine—Crohn's disease	0.000588	0.00109	CcSEcCtD
Venlafaxine—Pancreatitis—Prednisone—Crohn's disease	0.000574	0.00106	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000573	0.00106	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—MLN—Crohn's disease	0.00057	0.00776	CbGpPWpGaD
Venlafaxine—Feeling abnormal—Azathioprine—Crohn's disease	0.000569	0.00105	CcSEcCtD
Venlafaxine—Insomnia—Mesalazine—Crohn's disease	0.000569	0.00105	CcSEcCtD
Venlafaxine—Paraesthesia—Mesalazine—Crohn's disease	0.000565	0.00104	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000565	0.00104	CcSEcCtD
Venlafaxine—Dyspnoea—Mesalazine—Crohn's disease	0.000561	0.00104	CcSEcCtD
Venlafaxine—Somnolence—Mesalazine—Crohn's disease	0.00056	0.00103	CcSEcCtD
Venlafaxine—Dyspepsia—Mesalazine—Crohn's disease	0.000554	0.00102	CcSEcCtD
Venlafaxine—Neutropenia—Prednisone—Crohn's disease	0.000548	0.00101	CcSEcCtD
Venlafaxine—Decreased appetite—Mesalazine—Crohn's disease	0.000547	0.00101	CcSEcCtD
Venlafaxine—Abdominal pain—Azathioprine—Crohn's disease	0.000546	0.00101	CcSEcCtD
Venlafaxine—Body temperature increased—Azathioprine—Crohn's disease	0.000546	0.00101	CcSEcCtD
Venlafaxine—CYP2C19—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000546	0.00743	CbGpPWpGaD
Venlafaxine—Fatigue—Mesalazine—Crohn's disease	0.000543	0.001	CcSEcCtD
Venlafaxine—Erectile dysfunction—Prednisone—Crohn's disease	0.000539	0.000996	CcSEcCtD
Venlafaxine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000538	0.00733	CbGpPWpGaD
Venlafaxine—Constipation—Mesalazine—Crohn's disease	0.000538	0.000994	CcSEcCtD
Venlafaxine—Pain—Mesalazine—Crohn's disease	0.000538	0.000994	CcSEcCtD
Venlafaxine—Weight increased—Prednisone—Crohn's disease	0.000533	0.000985	CcSEcCtD
Venlafaxine—Weight decreased—Prednisone—Crohn's disease	0.00053	0.000979	CcSEcCtD
Venlafaxine—Hyperglycaemia—Prednisone—Crohn's disease	0.000528	0.000976	CcSEcCtD
Venlafaxine—Depression—Prednisone—Crohn's disease	0.000521	0.000962	CcSEcCtD
Venlafaxine—Feeling abnormal—Mesalazine—Crohn's disease	0.000519	0.000958	CcSEcCtD
Venlafaxine—Acute coronary syndrome—Prednisone—Crohn's disease	0.000515	0.000951	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000515	0.000951	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Prednisone—Crohn's disease	0.000512	0.000946	CcSEcCtD
Venlafaxine—Myocardial infarction—Prednisone—Crohn's disease	0.000512	0.000946	CcSEcCtD
Venlafaxine—NPY1R—GPCR ligand binding—CCR6—Crohn's disease	0.00051	0.00694	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Azathioprine—Crohn's disease	0.000509	0.000941	CcSEcCtD
Venlafaxine—SLC6A4—Monoamine Transport—IL1B—Crohn's disease	0.000503	0.00685	CbGpPWpGaD
Venlafaxine—Urticaria—Mesalazine—Crohn's disease	0.0005	0.000924	CcSEcCtD
Venlafaxine—CYP2C9—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000498	0.00678	CbGpPWpGaD
Venlafaxine—Body temperature increased—Mesalazine—Crohn's disease	0.000498	0.000919	CcSEcCtD
Venlafaxine—Abdominal pain—Mesalazine—Crohn's disease	0.000498	0.000919	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—LRRK2—Crohn's disease	0.000494	0.00672	CbGpPWpGaD
Venlafaxine—Bradycardia—Prednisone—Crohn's disease	0.000477	0.000882	CcSEcCtD
Venlafaxine—Diarrhoea—Azathioprine—Crohn's disease	0.000473	0.000874	CcSEcCtD
Venlafaxine—Haemoglobin—Prednisone—Crohn's disease	0.000471	0.00087	CcSEcCtD
Venlafaxine—Haemorrhage—Prednisone—Crohn's disease	0.000469	0.000866	CcSEcCtD
Venlafaxine—Hallucination—Prednisone—Crohn's disease	0.000466	0.000862	CcSEcCtD
Venlafaxine—Hypersensitivity—Mesalazine—Crohn's disease	0.000464	0.000857	CcSEcCtD
Venlafaxine—Dizziness—Azathioprine—Crohn's disease	0.000457	0.000844	CcSEcCtD
Venlafaxine—Asthenia—Mesalazine—Crohn's disease	0.000452	0.000834	CcSEcCtD
Venlafaxine—NPY1R—GPCR ligand binding—PTGER4—Crohn's disease	0.000449	0.00611	CbGpPWpGaD
Venlafaxine—Pruritus—Mesalazine—Crohn's disease	0.000445	0.000823	CcSEcCtD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000443	0.00604	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000443	0.00604	CbGpPWpGaD
Venlafaxine—Vomiting—Azathioprine—Crohn's disease	0.000439	0.000812	CcSEcCtD
Venlafaxine—Rash—Azathioprine—Crohn's disease	0.000436	0.000805	CcSEcCtD
Venlafaxine—Dermatitis—Azathioprine—Crohn's disease	0.000435	0.000804	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—CCR9—Crohn's disease	0.000435	0.00592	CbGpPWpGaD
Venlafaxine—Flushing—Prednisone—Crohn's disease	0.000435	0.000804	CcSEcCtD
Venlafaxine—Headache—Azathioprine—Crohn's disease	0.000433	0.0008	CcSEcCtD
Venlafaxine—SLC6A2—Monoamine Transport—IL1B—Crohn's disease	0.000433	0.00589	CbGpPWpGaD
Venlafaxine—Diarrhoea—Mesalazine—Crohn's disease	0.000431	0.000796	CcSEcCtD
Venlafaxine—Arrhythmia—Prednisone—Crohn's disease	0.000419	0.000774	CcSEcCtD
Venlafaxine—Dizziness—Mesalazine—Crohn's disease	0.000416	0.000769	CcSEcCtD
Venlafaxine—Alopecia—Prednisone—Crohn's disease	0.000414	0.000765	CcSEcCtD
Venlafaxine—Nausea—Azathioprine—Crohn's disease	0.00041	0.000758	CcSEcCtD
Venlafaxine—Erythema—Prednisone—Crohn's disease	0.000408	0.000754	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—GPR65—Crohn's disease	0.000405	0.00551	CbGpPWpGaD
Venlafaxine—Vomiting—Mesalazine—Crohn's disease	0.0004	0.000739	CcSEcCtD
Venlafaxine—Rash—Mesalazine—Crohn's disease	0.000397	0.000733	CcSEcCtD
Venlafaxine—Dermatitis—Mesalazine—Crohn's disease	0.000397	0.000733	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—CCR9—Crohn's disease	0.000395	0.00538	CbGpPWpGaD
Venlafaxine—Headache—Mesalazine—Crohn's disease	0.000394	0.000729	CcSEcCtD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000393	0.00535	CbGpPWpGaD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000393	0.00535	CbGpPWpGaD
Venlafaxine—Vision blurred—Prednisone—Crohn's disease	0.000385	0.00071	CcSEcCtD
Venlafaxine—SLC6A3—Monoamine Transport—IL1B—Crohn's disease	0.000383	0.00522	CbGpPWpGaD
Venlafaxine—Ill-defined disorder—Prednisone—Crohn's disease	0.000379	0.000699	CcSEcCtD
Venlafaxine—Anaemia—Prednisone—Crohn's disease	0.000377	0.000697	CcSEcCtD
Venlafaxine—Agitation—Prednisone—Crohn's disease	0.000375	0.000693	CcSEcCtD
Venlafaxine—Nausea—Mesalazine—Crohn's disease	0.000374	0.000691	CcSEcCtD
Venlafaxine—Angioedema—Prednisone—Crohn's disease	0.000373	0.000689	CcSEcCtD
Venlafaxine—Malaise—Prednisone—Crohn's disease	0.000368	0.00068	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—GPR65—Crohn's disease	0.000367	0.005	CbGpPWpGaD
Venlafaxine—Vertigo—Prednisone—Crohn's disease	0.000367	0.000677	CcSEcCtD
Venlafaxine—Syncope—Prednisone—Crohn's disease	0.000366	0.000676	CcSEcCtD
Venlafaxine—SLC6A4—Monoamine Transport—TNF—Crohn's disease	0.000365	0.00497	CbGpPWpGaD
Venlafaxine—ABCG2—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000362	0.00493	CbGpPWpGaD
Venlafaxine—Loss of consciousness—Prednisone—Crohn's disease	0.000359	0.000663	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—ACKR2—Crohn's disease	0.000355	0.00484	CbGpPWpGaD
Venlafaxine—Convulsion—Prednisone—Crohn's disease	0.000354	0.000653	CcSEcCtD
Venlafaxine—Hypertension—Prednisone—Crohn's disease	0.000352	0.000651	CcSEcCtD
Venlafaxine—Arthralgia—Prednisone—Crohn's disease	0.000347	0.000642	CcSEcCtD
Venlafaxine—Myalgia—Prednisone—Crohn's disease	0.000347	0.000642	CcSEcCtD
Venlafaxine—Anxiety—Prednisone—Crohn's disease	0.000346	0.00064	CcSEcCtD
Venlafaxine—Discomfort—Prednisone—Crohn's disease	0.000343	0.000634	CcSEcCtD
Venlafaxine—SLC6A3—Dopaminergic Neurogenesis—STAT3—Crohn's disease	0.000338	0.00461	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MLN—Crohn's disease	0.000337	0.00458	CbGpPWpGaD
Venlafaxine—Anaphylactic shock—Prednisone—Crohn's disease	0.000333	0.000615	CcSEcCtD
Venlafaxine—Oedema—Prednisone—Crohn's disease	0.000333	0.000615	CcSEcCtD
Venlafaxine—Infection—Prednisone—Crohn's disease	0.000331	0.000611	CcSEcCtD
Venlafaxine—Shock—Prednisone—Crohn's disease	0.000328	0.000605	CcSEcCtD
Venlafaxine—Tachycardia—Prednisone—Crohn's disease	0.000325	0.0006	CcSEcCtD
Venlafaxine—Hyperhidrosis—Prednisone—Crohn's disease	0.000322	0.000595	CcSEcCtD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000322	0.00438	CbGpPWpGaD
Venlafaxine—Anorexia—Prednisone—Crohn's disease	0.000317	0.000586	CcSEcCtD
Venlafaxine—SLC6A2—Monoamine Transport—TNF—Crohn's disease	0.000314	0.00427	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000312	0.00425	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TAGAP—Crohn's disease	0.000308	0.00419	CbGpPWpGaD
Venlafaxine—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000303	0.000561	CcSEcCtD
Venlafaxine—Insomnia—Prednisone—Crohn's disease	0.000301	0.000556	CcSEcCtD
Venlafaxine—Paraesthesia—Prednisone—Crohn's disease	0.000299	0.000552	CcSEcCtD
Venlafaxine—Dyspepsia—Prednisone—Crohn's disease	0.000293	0.000542	CcSEcCtD
Venlafaxine—Decreased appetite—Prednisone—Crohn's disease	0.00029	0.000535	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—CCR6—Crohn's disease	0.000288	0.00392	CbGpPWpGaD
Venlafaxine—Fatigue—Prednisone—Crohn's disease	0.000287	0.00053	CcSEcCtD
Venlafaxine—Constipation—Prednisone—Crohn's disease	0.000285	0.000526	CcSEcCtD
Venlafaxine—SLC6A3—Monoamine Transport—TNF—Crohn's disease	0.000278	0.00379	CbGpPWpGaD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000277	0.00377	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000276	0.00376	CbGpPWpGaD
Venlafaxine—Feeling abnormal—Prednisone—Crohn's disease	0.000274	0.000507	CcSEcCtD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000273	0.00372	CbGpPWpGaD
Venlafaxine—Gastrointestinal pain—Prednisone—Crohn's disease	0.000272	0.000503	CcSEcCtD
Venlafaxine—NPY1R—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000271	0.0037	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL10—Crohn's disease	0.00027	0.00368	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—RSPO3—Crohn's disease	0.000269	0.00367	CbGpPWpGaD
Venlafaxine—CYP2B6—Metapathway biotransformation—GPX4—Crohn's disease	0.000265	0.00361	CbGpPWpGaD
Venlafaxine—Urticaria—Prednisone—Crohn's disease	0.000265	0.000489	CcSEcCtD
Venlafaxine—Body temperature increased—Prednisone—Crohn's disease	0.000263	0.000486	CcSEcCtD
Venlafaxine—Abdominal pain—Prednisone—Crohn's disease	0.000263	0.000486	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—CCR6—Crohn's disease	0.000262	0.00356	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—IL17A—Crohn's disease	0.000259	0.00353	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—SEL1L—Crohn's disease	0.000255	0.00347	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—PTGER4—Crohn's disease	0.000254	0.00345	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Prednisone—Crohn's disease	0.000245	0.000453	CcSEcCtD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000245	0.00333	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—IL12B—Crohn's disease	0.000241	0.00328	CbGpPWpGaD
Venlafaxine—Asthenia—Prednisone—Crohn's disease	0.000239	0.000441	CcSEcCtD
Venlafaxine—Pruritus—Prednisone—Crohn's disease	0.000236	0.000435	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—CCR9—Crohn's disease	0.000233	0.00318	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—PTGER4—Crohn's disease	0.00023	0.00314	CbGpPWpGaD
Venlafaxine—Diarrhoea—Prednisone—Crohn's disease	0.000228	0.000421	CcSEcCtD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000225	0.00307	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000225	0.00307	CbGpPWpGaD
Venlafaxine—Dizziness—Prednisone—Crohn's disease	0.00022	0.000407	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—GPR65—Crohn's disease	0.000217	0.00295	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—IL3—Crohn's disease	0.000216	0.00294	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000216	0.00294	CbGpPWpGaD
Venlafaxine—Vomiting—Prednisone—Crohn's disease	0.000212	0.000391	CcSEcCtD
Venlafaxine—Rash—Prednisone—Crohn's disease	0.00021	0.000388	CcSEcCtD
Venlafaxine—Dermatitis—Prednisone—Crohn's disease	0.00021	0.000388	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000209	0.00285	CbGpPWpGaD
Venlafaxine—Headache—Prednisone—Crohn's disease	0.000209	0.000385	CcSEcCtD
Venlafaxine—CYP2C19—Metapathway biotransformation—GPX4—Crohn's disease	0.0002	0.00273	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.0002	0.00272	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.0002	0.00272	CbGpPWpGaD
Venlafaxine—Nausea—Prednisone—Crohn's disease	0.000198	0.000365	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—IL3—Crohn's disease	0.000196	0.00267	CbGpPWpGaD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000196	0.00267	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—RASGRP1—Crohn's disease	0.00019	0.00258	CbGpPWpGaD
Venlafaxine—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	0.000184	0.00251	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000184	0.0025	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000184	0.0025	CbGpPWpGaD
Venlafaxine—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	0.000183	0.00249	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—IL10—Crohn's disease	0.000176	0.0024	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CXCL8—Crohn's disease	0.000164	0.00224	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000159	0.00216	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	0.000157	0.00214	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCR6—Crohn's disease	0.000155	0.00211	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—IL2RA—Crohn's disease	0.000151	0.00206	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.000148	0.00201	CbGpPWpGaD
Venlafaxine—CYP2C19—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000147	0.002	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000142	0.00193	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000141	0.00191	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.00014	0.00191	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—RBX1—Crohn's disease	0.00014	0.0019	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—IL2RA—Crohn's disease	0.000137	0.00187	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PTGER4—Crohn's disease	0.000136	0.00185	CbGpPWpGaD
Venlafaxine—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000134	0.00182	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000129	0.00176	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000126	0.00171	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000124	0.00169	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—UBE2D1—Crohn's disease	0.000123	0.00167	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	0.00012	0.00164	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—RIPK2—Crohn's disease	0.000119	0.00162	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—IL3—Crohn's disease	0.000116	0.00158	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000115	0.00156	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000114	0.00156	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—RASGRP1—Crohn's disease	0.000112	0.00153	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000111	0.00151	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000107	0.00146	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—IFNG—Crohn's disease	0.000104	0.00141	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000103	0.0014	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—JAK2—Crohn's disease	0.000102	0.00139	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—SOCS1—Crohn's disease	0.000102	0.00138	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PLA2G4F—Crohn's disease	0.000101	0.00138	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	9.94e-05	0.00135	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	9.92e-05	0.00135	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	9.92e-05	0.00135	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	9.75e-05	0.00133	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—TYK2—Crohn's disease	9.69e-05	0.00132	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	9.64e-05	0.00131	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—CXCL8—Crohn's disease	9.29e-05	0.00126	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—IL1B—Crohn's disease	9.24e-05	0.00126	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—JAK2—Crohn's disease	9.24e-05	0.00126	CbGpPWpGaD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—ALB—Crohn's disease	8.81e-05	0.0012	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—SMAD3—Crohn's disease	8.77e-05	0.00119	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—MTMR3—Crohn's disease	8.6e-05	0.00117	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CXCL8—Crohn's disease	8.43e-05	0.00115	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	8.33e-05	0.00113	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL6—Crohn's disease	8.29e-05	0.00113	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—IL2RA—Crohn's disease	8.12e-05	0.00111	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	7.8e-05	0.00106	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	7.6e-05	0.00103	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PLA2G4F—Crohn's disease	7.41e-05	0.00101	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	7.11e-05	0.000968	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	6.99e-05	0.000952	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—IL6—Crohn's disease	6.77e-05	0.000922	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—TNF—Crohn's disease	6.71e-05	0.000913	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—FADS1—Crohn's disease	6.7e-05	0.000912	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—MTMR3—Crohn's disease	6.3e-05	0.000858	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GPX4—Crohn's disease	6.27e-05	0.000854	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.18e-05	0.000841	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GCKR—Crohn's disease	6.06e-05	0.000825	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TYK2—Crohn's disease	5.72e-05	0.000779	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	5.6e-05	0.000762	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PLA2G4F—Crohn's disease	5.47e-05	0.000744	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—JAK2—Crohn's disease	5.46e-05	0.000743	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	5.15e-05	0.000701	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	5.11e-05	0.000695	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—ALB—Crohn's disease	5.05e-05	0.000688	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CXCL8—Crohn's disease	4.98e-05	0.000678	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—FADS1—Crohn's disease	4.91e-05	0.000668	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	4.9e-05	0.000668	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—MTMR3—Crohn's disease	4.76e-05	0.000648	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—IL6—Crohn's disease	4.74e-05	0.000645	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—MTMR3—Crohn's disease	4.65e-05	0.000633	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GPX4—Crohn's disease	4.6e-05	0.000626	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—ALB—Crohn's disease	4.48e-05	0.000609	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GCKR—Crohn's disease	4.44e-05	0.000604	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—MTMR3—Crohn's disease	4.38e-05	0.000596	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—MTMR3—Crohn's disease	4.34e-05	0.000591	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—ALB—Crohn's disease	4.12e-05	0.00056	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—STAT3—Crohn's disease	4.01e-05	0.000546	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—FADS1—Crohn's disease	3.71e-05	0.000505	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—FADS1—Crohn's disease	3.62e-05	0.000493	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GPX4—Crohn's disease	3.47e-05	0.000473	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—FADS1—Crohn's disease	3.41e-05	0.000465	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GPX4—Crohn's disease	3.39e-05	0.000462	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—FADS1—Crohn's disease	3.38e-05	0.000461	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	3.37e-05	0.000459	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GCKR—Crohn's disease	3.36e-05	0.000457	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	3.31e-05	0.000451	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GCKR—Crohn's disease	3.27e-05	0.000446	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GPX4—Crohn's disease	3.2e-05	0.000435	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GPX4—Crohn's disease	3.17e-05	0.000431	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GCKR—Crohn's disease	3.09e-05	0.00042	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GCKR—Crohn's disease	3.06e-05	0.000416	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—MTMR3—Crohn's disease	2.86e-05	0.00039	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—IL6—Crohn's disease	2.8e-05	0.000381	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.4e-05	0.000326	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—FADS1—Crohn's disease	2.23e-05	0.000304	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.23e-05	0.000303	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.19e-05	0.000298	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.1e-05	0.000286	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GPX4—Crohn's disease	2.09e-05	0.000284	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GCKR—Crohn's disease	2.02e-05	0.000275	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ALB—Crohn's disease	1.93e-05	0.000262	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.91e-05	0.00026	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PTGS2—Crohn's disease	1.69e-05	0.00023	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ALB—Crohn's disease	1.41e-05	0.000192	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PTGS2—Crohn's disease	1.24e-05	0.000168	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ALB—Crohn's disease	1.07e-05	0.000145	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ALB—Crohn's disease	1.04e-05	0.000142	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ALB—Crohn's disease	9.82e-06	0.000134	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ALB—Crohn's disease	9.74e-06	0.000133	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PTGS2—Crohn's disease	9.34e-06	0.000127	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PTGS2—Crohn's disease	9.12e-06	0.000124	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PTGS2—Crohn's disease	8.59e-06	0.000117	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PTGS2—Crohn's disease	8.52e-06	0.000116	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ALB—Crohn's disease	6.42e-06	8.74e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PTGS2—Crohn's disease	5.62e-06	7.65e-05	CbGpPWpGaD
